171 related articles for article (PubMed ID: 12177781)
1. Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.
Andachi H; Yashima K; Koda M; Kawaguchi K; Kitamura A; Hosoda A; Kishimoto Y; Shiota G; Ito H; Makino M; Kaibara N; Kawasaki H; Murawaki Y
Br J Cancer; 2002 Aug; 87(4):441-5. PubMed ID: 12177781
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma.
Koda M; Yashima K; Kawaguchi K; Andachi H; Hosoda A; Shiota G; Ito H; Murawaki Y
Cancer Lett; 2003 Sep; 199(2):131-8. PubMed ID: 12969785
[TBL] [Abstract][Full Text] [Related]
3. Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype.
Kawaguchi K; Yashima K; Koda M; Tsutsumi A; Kitaoka S; Andachi H; Hosoda A; Kishimoto Y; Shiota G; Ito H; Murawaki Y
Br J Cancer; 2004 Feb; 90(3):672-7. PubMed ID: 14760383
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
Yao CC; Lin CY; Hu MB
Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
[TBL] [Abstract][Full Text] [Related]
5. Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer.
Sarli L; Bottarelli L; Azzoni C; Campanini N; Di Cola G; Bader G; Iusco D; Salvemini C; Caruso G; Donadei E; Pizzi S; D'Adda T; Renato C; Roncoroni L; Bordi C
Eur J Cancer; 2004 Jul; 40(10):1581-8. PubMed ID: 15196543
[TBL] [Abstract][Full Text] [Related]
6. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
[TBL] [Abstract][Full Text] [Related]
7. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.
Turner BC; Ottey M; Zimonjic DB; Potoczek M; Hauck WW; Pequignot E; Keck-Waggoner CL; Sevignani C; Aldaz CM; McCue PA; Palazzo J; Huebner K; Popescu NC
Cancer Res; 2002 Jul; 62(14):4054-60. PubMed ID: 12124341
[TBL] [Abstract][Full Text] [Related]
8. Fhit, Mlh1, P53 and phenotypic expression in the early stage of colorectal neoplasms.
Yasugi A; Yashima K; Hara A; Koda M; Kawaguchi K; Harada K; Andachi H; Murawaki Y
Oncol Rep; 2008 Jan; 19(1):41-7. PubMed ID: 18097574
[TBL] [Abstract][Full Text] [Related]
9. Mismatch repair, p53 and chromosomal aberrations in primary colorectal carcinomas.
Mehigan BJ; Ashman JN; Baker RP; Macdonald A; Greenman J; Monson JR; Cawkwell L
Acta Oncol; 2006; 45(1):61-6. PubMed ID: 16464797
[TBL] [Abstract][Full Text] [Related]
10. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.
Hao XP; Willis JE; Pretlow TG; Rao JS; MacLennan GT; Talbot IC; Pretlow TP
Cancer Res; 2000 Jan; 60(1):18-21. PubMed ID: 10646844
[TBL] [Abstract][Full Text] [Related]
11. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
[TBL] [Abstract][Full Text] [Related]
12. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
13. Fhit protein expression in hereditary and sporadic colorectal cancers.
Hadaczek P; Debniak T; Kurzawski G; Jakubowska A; Huzarski T; Huebner K; Lubiński J
Pol J Pathol; 2001; 52(3):125-32. PubMed ID: 11769399
[TBL] [Abstract][Full Text] [Related]
14. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer.
Park IJ; Kim HC; Kim JS; Yu ES; Yu CS; Kim JC
Hepatogastroenterology; 2005; 52(62):450-4. PubMed ID: 15816455
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of Fhit expression in development of colorectal carcinoma of various macroscopic types.
Kuwai T; Tanaka S; Kaio E; Hiyama T; Ito M; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
Int J Mol Med; 2003 Oct; 12(4):437-42. PubMed ID: 12964015
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
[TBL] [Abstract][Full Text] [Related]
17. Loss of fragile histidine triad expression in colorectal carcinoma.
Zhao P; Lu Y; Hu Y; Zhong M; Li Z; Li X
Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):124-7. PubMed ID: 12419158
[TBL] [Abstract][Full Text] [Related]
18. Mismatch repair, p53 and beta-catenin proteins in colorectal cancer.
Valentini AM; Renna L; Armentano R; Pirrelli M; Di Leo A; Gentile M; Caruso ML
Anticancer Res; 2002; 22(4):2083-8. PubMed ID: 12174887
[TBL] [Abstract][Full Text] [Related]
19. Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma.
Mori M; Mimori K; Masuda T; Yoshinaga K; Yamashita K; Matsuyama A; Inoue H
Cancer Res; 2001 Oct; 61(20):7379-82. PubMed ID: 11606365
[TBL] [Abstract][Full Text] [Related]
20. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.
Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR
Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
